Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund and Insider Trading News: Eddie Lampert, Citadel Investment Group, Point72, Axon Enterprise Inc (AAXN), Strongbridge Biopharma PLC (SBBP), and More

Eddie Lampert Wants to Save Sears but Mall Owners Say Don’t Bother (The Wall Street Journal)
Shopping center owners usually dread the prospect of a big retail operator shutting its doors. In the case of Sears Holding Corp., many landlords are welcoming it. That is in large part because these owners have lost faith in Sears chairman Eddie Lampert, his plans to salvage the company and a brand that they view as outdated, many big landlords and retail analysts say.

Citadel Hedge Fund Gains 9% in Strong Multi-Strategy Year (Bloomberg)
Big multi-strategy hedge funds found a way to make money in a tumultuous year when so many other firms floundered. Ken Griffin’s Citadel, which runs more than $30 billion, rose 9.1 percent in its flagship Wellington hedge fund last year, and Izzy Englander’s $35 billion Millennium Management gained nearly 5 percent, according to people familiar with the matter. Hudson Bay Capital Management, which manages $3 billion, returned 6.5 percent, another person said.

buy, sell, sale, trading, market, business, stock, trade, fund,

Ismagilov/shutterstock.com

What Regular Investors Can Learn from Bridgewater’s Stellar 2018 Performance (MarketWatch)
Bridgewater Associate’s Pure Alpha Strategy fund, benefiting from what billionaire founder Ray Dalio described as a “Goldilocks period” for the stock market, crushed the competition last year with a 14.6% gain. That’s a period in which the S&P 500 SPX, +0.18% lost 4.4%, and the average hedge fund lost 6.7%. Winners were, indeed, a rarity. Dalio didn’t get into the details of his outperformance, but he did share this “one important thought” in a LinkedIn post on Monday: ‘If you are worried when the stock market goes down and happy when it goes up, it probably indicates that your portfolio is unbalanced. If your income is also tied to how the economy does, you are doubly at risk because your portfolio can go down when your income is worst, which is scary.’

Why this Hedge Fund is Bullish on China (CNBC)
Marc Desmidt of Point72 says there are “fantastic” opportunities to deploy capital in China, and he is “excited” to tap into the health care, financial services and education sectors in the country.

Hedge Funds Lost Almost 6% Last Year as Markets Roiled Managers (Bloomberg)
Hedge funds posted a loss of 5.7 percent last year as managers struggled to capitalize on volatility and were roiled by political uncertainty. For December, funds lost 1.9 percent, according to preliminary figures from the Bloomberg Hedge Fund Database.

Insider Selling: Axon Enterprise Inc (NASDAQ:AAXN) CEO Sells 107,000 Shares of Stock (FairFieldCurrent.com)
Axon Enterprise Inc (NASDAQ:AAXN) CEO Patrick W. Smith sold 107,000 shares of the stock in a transaction that occurred on Thursday, December 20th. The stock was sold at an average price of $42.27, for a total value of $4,522,890.00. Following the sale, the chief executive officer now directly owns 632,520 shares in the company, valued at approximately $26,736,620.40. The sale was disclosed in a filing with the Securities & Exchange Commission.

Insider Buying: Strongbridge Biopharma plc (SBBP) Major Shareholder Buys 146,467 Shares of Stock (PressOracle.com)
Strongbridge Biopharma plc (NASDAQ:SBBP) major shareholder Associates L.L.C. Cdk purchased 146,467 shares of Strongbridge Biopharma stock in a transaction on Thursday, December 20th. The stock was bought at an average cost of $4.00 per share, with a total value of $585,868.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission.

Insider Selling: Virtusa Co. (VRTU) CEO Sells 12,000 Shares of Stock (WeekHerald.com)
Virtusa Co. (NASDAQ:VRTU) CEO Kris A. Canekeratne sold 12,000 shares of the business’s stock in a transaction dated Friday, January 4th. The shares were sold at an average price of $42.06, for a total transaction of $504,720.00. Following the completion of the sale, the chief executive officer now directly owns 661,387 shares of the company’s stock, valued at approximately $27,817,937.22. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Insider Selling: Teladoc Health Inc (NYSE:TDOC) CEO Sells 30,000 Shares of Stock (PressOracle.com)
Teladoc Health Inc (NYSE:TDOC) CEO Jason N. Gorevic sold 30,000 shares of the firm’s stock in a transaction dated Wednesday, December 19th. The stock was sold at an average price of $49.55, for a total value of $1,486,500.00. Following the transaction, the chief executive officer now directly owns 536,184 shares in the company, valued at approximately $26,567,917.20. The sale was disclosed in a document filed with the Securities & Exchange Commission.

Insider Selling: Docusign Inc (DOCU) Director Sells 51,982 Shares of Stock (FairFieldCurrent.com)
Docusign Inc (NASDAQ:DOCU) Director Keith J. Krach sold 51,982 shares of the business’s stock in a transaction on Friday, December 21st. The shares were sold at an average price of $40.34, for a total transaction of $2,096,953.88. The sale was disclosed in a legal filing with the SEC.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...